The pharmaceutical sector is facing an unprecedented period of patent expiries when mega-blockbusters including Pfizer’s Lipitor, Bristol-Myers Squibb‘s Plavix and Eli Lilly’s Zyprexa will be exposed to cheap,
The samples will be shipped for the approval of the US FDA before it can introduce the products. Glenmark has invested about $20m in the plant that has
The Data Monitoring Committee decided to stop enrollment following an independent recommendation that no new or recently enrolled patients continue treatment in the trial because of safety concerns
Trabedersen is a first-in-class gene silencing antisense compound designed to inhibit the tumour factor – transforming growth factor beta 2 (TGF-ß2) at its translational level. The efficacy and
The DeepSeq Solution is based on the proven RainStorm microdroplet-based single molecule PCR technology and is optimised for both fresh frozen and FFPE tissue. It delivers high specificity,
According to the lawsuit, FDA has knowingly allowed sodium thiopental, which has not been approved by the FDA, to be imported by state corrections agencies for use in
For the fourth quarter of 2010, the company posted an operating income of $367.4m, compared to $316.9m for the same period in 2009. For the full year ended
The company has successfully completed two Phase I trials of EGEN-001, in which the treatment resulted in good safety, biological activity and encouraging efficacy. EGEN-001 received Orphan Drug
Fera Pharma is launching Puralube in a 3.5g tube as well as a carton of 20 1g tubes. Fera Pharmaceuticals has launched its over-the-counter (OTC) dry eye treatment,
Shire claims that Vyvanse is the first and only once-daily prodrug stimulant approved to treat ADHD in adolescents and adults. The FDA’s approval of Vyvanse in adolescents and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.